Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Depreciation and Depletion (2016 - 2025)

Historic Depreciation and Depletion for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to $132.0 million.

  • Bristol Myers Squibb's Depreciation and Depletion fell 2189.35% to $132.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $621.0 million, marking a year-over-year decrease of 460.83%. This contributed to the annual value of $621.0 million for FY2025, which is 460.83% down from last year.
  • According to the latest figures from Q4 2025, Bristol Myers Squibb's Depreciation and Depletion is $132.0 million, which was down 2189.35% from $159.0 million recorded in Q3 2025.
  • In the past 5 years, Bristol Myers Squibb's Depreciation and Depletion registered a high of $169.0 million during Q4 2024, and its lowest value of $132.0 million during Q4 2025.
  • Its 5-year average for Depreciation and Depletion is $151.4 million, with a median of $151.0 million in 2023.
  • As far as peak fluctuations go, Bristol Myers Squibb's Depreciation and Depletion skyrocketed by 1167.88% in 2022, and later plummeted by 2189.35% in 2025.
  • Over the past 5 years, Bristol Myers Squibb's Depreciation and Depletion (Quarter) stood at $137.0 million in 2021, then rose by 11.68% to $153.0 million in 2022, then increased by 6.54% to $163.0 million in 2023, then grew by 3.68% to $169.0 million in 2024, then decreased by 21.89% to $132.0 million in 2025.
  • Its Depreciation and Depletion was $132.0 million in Q4 2025, compared to $159.0 million in Q3 2025 and $165.0 million in Q2 2025.